Changing face of dyslipidemia therapy.
dc.contributor.author | Banerjee, Amal Kumar | en_US |
dc.date.accessioned | 2008-05-26 | en_US |
dc.date.accessioned | 2009-05-27T04:29:47Z | |
dc.date.available | 2008-05-26 | en_US |
dc.date.available | 2009-05-27T04:29:47Z | |
dc.date.issued | 2008-05-26 | en_US |
dc.identifier.citation | Banerjee AK. Changing face of dyslipidemia therapy. Indian Heart Journal. 2008 May-Jun; 60(3): 192-4 | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/5925 | |
dc.language.iso | eng | en_US |
dc.source.uri | https://indianheartjournal.com | en_US |
dc.subject.mesh | Anticholesteremic Agents --therapeutic use | en_US |
dc.subject.mesh | Cholesterol, HDL --drug effects | en_US |
dc.subject.mesh | Cholesterol, LDL --drug effects | en_US |
dc.subject.mesh | Coronary Artery Disease --drug therapy | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Hydroxymethylglutaryl-CoA Reductase Inhibitors --therapeutic use | en_US |
dc.subject.mesh | Hyperlipidemias --drug therapy | en_US |
dc.title | Changing face of dyslipidemia therapy. | en_US |
dc.type | Comment | en_US |
dc.type | Editorial | en_US |
Files
License bundle
1 - 1 of 1